Loading the security page…
A security analysis is not yet prepared for this market.
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Fennec Pharmaceuticals Inc. (FENC) is a company in the Health care sector; its shares trade on Nasdaq.
The price of Fennec Pharmaceuticals Inc. (FENC) on November 12, 2026 is 11.03 $, +3.67 % on the day. Over 52 weeks the stock traded between 5.65 $ and 13.25 $; the price now sits 71 % of the way up that range. Over the past year the price changed by +45.37 %. Market capitalization is 375.91 million $, rank 53 among 134 stocks of the same industry with a known capitalization.
Fennec Pharmaceuticals Inc. trades on Nasdaq under the ticker FENC. The company belongs to the Health care sector. The trading history on this page starts on 15 September 2017.
Over the past 52 weeks FENC has traded between 5.65 $ and 13.25 $. As of 12 November 2026 the price stood 74.47% of the way from the 52-week low to the high.
Over one year FENC shares rose 45.37%; over six months they rose 22.40%. Volatility over 90 days is 60.02%. Dividends are not included: this is price change only, as of 12 November 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 6.3, above the sector median of 3.9. Price to book is 8.9, above the sector median of 2.4. Calculated from reports for the period ending 30 June 2026.
Fennec Pharmaceuticals Inc. reported revenue of 59M $ and a net loss of 3M $ over the last four quarters. Net margin is −5.49%. Revenue changed by +77.83% year over year. Earnings per share are −$0.12. Market capitalisation is 376M $.
FENC has a return on equity of −7.66%, above the sector median of −40.58%. Return on assets is −4.29%, above the sector median of −30.08%. Operating margin is −1.90%, above the sector median of −20.96%.